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Supplementary Materials and Methods
General Maintenance and Husbandry
The general maintenance and husbandry was according to our previously published procedures 1 . Briefly, the Comprehensive Lab Animal Monitoring System (CLAMS®, Columbus Instruments; Columbus, OH, USA) was started at 1100 h every day and stopped at 0900 h in the following day (22h measurement). General maintenance and husbandry including calibration of the sensors, filling of the feeders and water bottles were carried out between 0900 to 1100 h. Further, during this period, body weight and body composition measurements, intraperitoneal glucose tolerance test (IPGTT) and drug injections were conducted. Throughout the study period, the animals had ad libitum access to fresh food provided on alternate days and water except the days before IPGTT, drug injections and meal test when food was taken away but not water for 16 h (overnight fasting).
Measurements of Food Intake and Energy Expenditure
Food intake and energy expenditure were recorded daily by the CLAMS® system throughout the study as we reported previously 1 . Briefly, the rats had access to powdered food through a center feeder assembly resting on a balance, and the balance weights were recorded at ~30 sec intervals. The energy intake of individual rats was measured by multiplying the food intake (g) by physiological fuel value of diets (4.4 kcal/g). The total energy expenditure was measured by open circuit indirect calorimetry with negative flow controllers providing fresh-air to all chambers at 2 L/min. Air was sampled from each cage for 5 sec following a 55 sec stabilization period, and after every two cages, a reference air measurement was recorded. Each day before starting the CLAMS ® , the O2 and CO2 sensors were calibrated with a calibration gas (20.50% O2, 0.5% CO2) at 5-10 psi. Oxygen consumption rate (VO2 ml/kg body weight/h), carbon dioxide production rate (VCO2 ml/kg body weight/h) and respiratory exchange ratio (RER) were measured and the total energy expenditure was computed as calorific value (CV) × VO2, where CV = 3.815 + 1.232 × RER 2 and data were expressed as kcal/(kg lean mass/h).
Blood Sampling and Tissue Harvesting
Following our previous procedures 1, 3 , blood samples were collected on ice into tubes containing ethylenediaminetetraacetic acid (EDTA; 1.5 mg/ml blood), protease inhibitor cocktail (10 µl/ml blood; Sigma-Aldrich, Oakville, ON, Canada) and dipeptidyl peptidase IV inhibitor (DPP-IV inhibitor; 10 µl/ml blood; Millipore Corporation, Temecula, CA, USA). Samples were immediately centrifuged at 4°C (4,000 rpm for 15 min), plasma was collected and stored at -80°C until further analyses. Following the last blood sampling, the animals were euthanized by using sodium pentobarbital (120 mg/kg IP; Euthanyl®, Bimeda-MTC, ON, Canada) and interscapular brown adipose (BAT), liver, leg skeletal muscle, kidney and heart tissues were collected, rinsed in sterile phosphate buffer saline, weighed and immediately snap-frozen in liquid nitrogen, and stored at -80°C until further analyses. Liver lipid content was measured using a biopsy probe of the Minispec LF110® NMR Analyzer (Bruker Corporation, Milton, ON, Canada).
Measurement of Plasma Amino Acid Concentrations
Plasma amino acid concentrations were measured as described previously 4 . Briefly, plasma amino acid concentrations were measured for terminal samples collected at 120 min (except cystine, proline and hydroxy proline), by using a fluorometric high performance liquid15 s. Relative differences in the expression of target genes were determined using the 2 -∆∆CT method 6,7 .
